The most common known cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) is a hexanucleotide repeat expansion (HRE) in C9ORF72 that contributes to neurodegeneration by both loss-of-function (decreased C9ORF72 protein levels) and gain-offunction (e.g. dipeptide repeat protein production) mechanisms. Although therapeutics targeting the gain-of-function mechanisms are in clinical development, it is unclear if these will be efficacious given the contribution of C9ORF72 loss-of-function processes to neurodegeneration. Moreover, there is a lack of therapeutic strategies for C9ORF72 ALS/FTD with demonstrated efficacy in vivo. Here, we show that small molecule inhibition of PIKFYVE kinase rescues both loss-and gain-of-function C9ORF72 disease mechanisms in vivo. We find that the reduction of C9ORF72 in mouse motor neurons leads to a decrease in early endosomes. In contrast, treatment with the PIKFYVE inhibitor apilimod increases the number of endosomes and lysosomes. We show that reduced C9ORF72 levels increases glutamate receptor levels in hippocampal neurons in mice, and that apilimod treatment rescues this excitotoxicity-related phenotype in vivo. Finally, we show that apilimod also alleviates the gainof-function pathology induced by the C9ORF72 HRE by decreasing levels of dipeptide repeat proteins derived from both sense and antisense C9ORF72 transcripts in hippocampal neurons in vivo. Our data demonstrate the neuroprotective effect of PIKFYVE kinase inhibition in both gain-and loss-of-function murine models of C9ORF72 ALS/FTD.
Keywordsamyotrophic lateral sclerosis, frontotemporal dementia, apilimod, C9ORF72, NMDA-induced injury, endosomal trafficking, dipeptide repeat proteins, lysosomes, endosomes, glutamate receptors A. Images of EEA1+ vesicles in the hippocampus of C9-BAC mice treated by direct injection with DMSO or apilimod. Scale bar = 10 µm. B. Number of EEA1+ vesicles per cytosolic area in the hippocampus of C9-BAC mice treated by direct injection with apilimod (n=186 cells from 8 mice) or DMSO (vehicle, n=185 cells from 8 mice) for 48 hours. Mean +/-standard deviation, unpaired t-test. C. Number of EEA1+ vesicles per cytosolic area in the hippocampus of C9-BAC mice treated by direct injection with apilimod (n=8 mice) or DMSO (vehicle, n= 8 mice) for 48 hours. Median +/-interquartile range of cells for each mouse, unpaired t-test comparing mean values per mouse. Horizontal grey dotted line indicates the median number of EEA1+ vesicles per cytosolic area in the hippocampus of C9-BAC mice treated by direct injection with DMSO. D. Images of poly(GP)+ punctae in the hippocampus of C9-BAC mice 48 hours after being treated by direct injection with DMSO or apilimod. Scale bar = 10 µm.E. Number of poly(GP)+ punctae per neuronal area in the hippocampus of C9-BAC mice treated by direct injection with apilimod (n=150 cells from 9 mice) or DMSO (vehicle, n=150 cells from 9 mice) for 48 hours. Control group, included for reference, are untreated wild-type mice (n=125 cells from 6 mice). Median...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.